Search Results 21-30 of 7815 for SC
Michael P. Halasy, D.H.Sc., M.S., P.A.-C., conducts workforce and behavior research at Mayo Clinic to improve care delivery, and increase provider and ...
The primary purpose of this study is to demonstrate the effectiveness of efgartigimod PH20 SC compared to placebo in the treatment of patients with Pemphigus ...
Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple ...
This group of rare diseases involves the hardening and tightening of the skin and connective tissues. Some forms can affect internal organs.
In MS, the immune system attacks the protective sheath that covers nerve fibers, known as myelin. This interrupts communication between the brain and the rest ...
... SC. Minibeam Radiation Therapy Treatment (MBRT): Commissioning and First Clinical Implementation. Int J Radiat Oncol Biol Phys. 2024 Dec 1; 120 (5):1423 ...
Mayo Clinic researcher Khashayarsha Khazaie (Khash) Ph.D., D.Sc., conducts basic and translational research in cancer immunology and inflammation.
This mental condition can lead to hallucinations, delusions, and very disordered thinking and behavior. It can make daily living hard, but it's treatable.
Ketch PW, Dowdy SC, McBane RD 2nd, Michael Straughn J Jr, Boitano TKL. Direct oral anticoagulants (DOACs) for postoperative venous thromboembolism ...
A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Give by Dec. 31 to multiply your impact 3X.